IL22 and liver dysplastic nodule: Furthermore, through the NLRP3/caspase-1/IL-1β pathway, IL-22 can reverse the overexpression of fibronectin, collagen IV, and extracellular matrix in mouse renal glomerular mesangial cells, thereby ameliorating renal fibrosis and proteinuria excretion in DN (150, 180).